Dash Acquisitions Inc. Bristol Myers Squibb CO Transaction History
Dash Acquisitions Inc.
- $495 Million
- Q3 2025
A detailed history of Dash Acquisitions Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dash Acquisitions Inc. holds 5,400 shares of BMY stock, worth $248,508. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,400Holding current value
$248,508% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,670Shares Held
1.64BCall Options Held
22.5MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.97 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.3 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.36 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.26 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.8B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...